Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance

• KANTARJIAN HM

収録刊行物

• Blood

  Blood 110 (10), 3540-3546, 2007

詳細情報

• CRID: 1573387449789363584
• NII論文ID: 10029535148
• データソース種別:
  • CiNii Articles